ropren formats

Anyone with Big Balls ? someone take out 230000 shares and we get rid of the Pine tree shaker at 82 and rush back to 90cents pre plant commissioning. Guess we need some info on when the sales will start and how much to begin the begin? A string of announcements shortly would be a good momentum play and relief for the faithful.

This is a summary.

Ropren as used in the clinical trials and all subsequent human trials in
Russia is delivered in the form of drops - either orally or nasally.
All the liver disease trials involved oral delivery. Nasal delivery has
been used for some of the neurodegenerative disorder trials.

Only the dropper format will be available for sale in Russia when the
manufacturing licence comes through(now first stages).

The Australian trials at Swinburne used small capsules containing the
same substance used in the drops. The encapsulation was done in
Australia by Catalynt (formerly Cardinal Health).

We have an injectable form developed. That was a challenging process
because the injectable form needed to be water soluble and Ropren is oil
soluble. But the work has been done. This was developed at the request
of leading neurologists after the successful alzheimer's trials. We are
currently doing toxicity trials on this form.

We have also developed a liposomal format and that is also undergoing
trials. The advantage of liposomal form is that less is lost in the
digestive system. There are also economic advantages. It means using
potentially one or two orders of magnitude less Ropren for the same
effect. But it is still undergoing trials.

Finally, we have developed a nanoparticle format. We have said nothing
more about this beyond the fact that it has been developed and is
undergoing trials.

I think that covers the full spectrum of Ropren formats for now.